The Intellectual Property Office of the Philippines (Ipophl) has partnered with the Pharmaceutical Security Institute (PSI) to combat the increase of counterfeit medicines and pharmaceutical products in the market.
In a statement on Monday, Ipophl said it signed an agreement with PSI last November 18. "This synergy with PSI will help us better protect the value of IP that is meant for our country's economic gain and, of course, protect our consumers, especially where fake products involved can harm health and cost a life," Ipophl Director General Rowel Barba said. The agreement will the provide the framework for the capacity building, awareness and exchange of information relevant to curb the sale, supply and consumption of counterfeit medicines and pharmaceutical products.
Continue reading with one of these options:
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)